CurrentRheuma
Get Weekly

Topic · page 39 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 1,521–1,560 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

  1. J Rheumatol

    Risk Factors for Dementia in Patients With Incident Rheumatoid Arthritis: A Population-Based Cohort Study

    Cohort study

  2. Scand J Rheumatol

    Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial

    Secondary analysis

  3. Clin Exp Rheumatol

    Prevalence of frailty and pre-frailty in patients with rheumatoid arthritis: a systematic literature review and meta-analysis

    Meta-analysis

  4. Rheumatology (Oxford)

    Serum cholesterol loading capacity of macrophages is regulated by seropositivity and C-reactive protein in rheumatoid arthritis patients

    Cross-sectional study

  5. Clin Exp Rheumatol

    Prevalence and clinical significance of electrocardiographic signs of atrial myopathy in rheumatoid arthritis: results from the EDRA study

    Cohort study

  6. Clin Exp Rheumatol

    Changes of anti-citrullinated peptide antibodies titers after biologic treatment in patients with rheumatoid arthritis: a systematic literature review and retrospective study

    Cohort study

  7. Clin Exp Rheumatol

    Sustained effectiveness and safety of subcutaneous tocilizumab over two years in the ARATA observational study

    Cohort study

  8. Rheumatology (Oxford)

    Use of primary health care and radiological imaging preceding a diagnosis of rheumatoid arthritis: a nationwide cohort study in Denmark

    Cohort study

  9. Rheumatology (Oxford)

    Subclinical atherosclerosis profiles in rheumatoid arthritis and primary Sjögren’s syndrome: the impact of BAFF genetic variations

    Cross-sectional study

  10. Rheumatology (Oxford)

    L-shaped association between serum 25-hydroxyvitamin D and all-cause mortality of individuals with rheumatoid arthritis

    Cohort study

  11. Scand J Rheumatol

    Rheumatoid arthritis and the risk of major cardiometabolic diseases: a Mendelian randomization study

    Research article

  12. Clin Exp Rheumatol

    Are SMAD2/4/7 genetic variants associated with rheumatoid arthritis susceptibility and severity?

    Case-control study

  13. Clin Exp Rheumatol

    Lipid metabolomic signature might predict subclinical atherosclerosis in patients with active rheumatoid arthritis

    Cross-sectional study

  14. Rheumatology (Oxford)

    Improved outcomes in rheumatoid arthritis with obesity after a weight loss intervention: randomized trial

    Randomized controlled trial

  15. Clin Exp Rheumatol

    A link between CD8+CD27-CD28- T cells expressing chemerin chemokine-like receptor 1 and rheumatoid arthritis

    Mechanistic study

  16. Semin Arthritis Rheum

    Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group

    Research article

  17. Clin Exp Rheumatol

    A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification

    Cohort study

  18. Clin Exp Rheumatol

    Synovial fluid survivin and NETs as independent biomarkers in rheumatoid arthritis

    Cross-sectional study

  19. Scand J Rheumatol

    The changing incidence of rheumatoid arthritis over time in north-west Greece: data from a referral centre

    Cohort study

  20. Scand J Rheumatol

    Risk of Staphylococcus aureus bacteraemia in patients with rheumatoid arthritis and the effect of orthopaedic implants on the risk: a nationwide observational cohort study

    Cohort study

  21. Clin Exp Rheumatol

    Clinical and ultrasonographic evaluation of the window of opportunity for retreatment with rituximab in rheumatoid arthritis patients from a multicentre real-life study

    Cohort study

  22. Rheumatology (Oxford)

    The value of ultrasound-defined tenosynovitis and synovitis in the prediction of persistent arthritis

    Cohort study

  23. Clin Exp Rheumatol

    Efficacy and drug retention of tofacitinib in rheumatoid arthritis: from the nationwide Korean College of Rheumatology Biologics registry

    Cohort study

  24. Clin Exp Rheumatol

    Can numerical rating scales of disease impact be used as targets for patient-centred management in rheumatoid arthritis?

    Cohort study

  25. Clin Exp Rheumatol

    Switching from intravenous tocilizumab to subcutaneous administration during COVID-19 pandemic: impact on treatment efficacy and patient satisfaction

    Cohort study

  26. Scand J Rheumatol

    NT-proBNP and sRAGE levels in early rheumatoid arthritis

    Cohort study

  27. Scand J Rheumatol

    Trends in the occurrence of ischaemic heart disease over time in rheumatoid arthritis: 1821 patients from 1972 to 2017

    Cohort study

  28. Clin Exp Rheumatol

    Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort

    Cohort study

  29. Clin Exp Rheumatol

    Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres

    Cohort study

  30. Clin Exp Rheumatol

    Real-world data on seropositive rheumatoid arthritis, then and now: ten-year outcomes of 1151 patients diagnosed between 1997 and 2011

    Cohort study

  31. Clin Exp Rheumatol

    Waning humoral immunity of SARS-CoV-2 vaccination in a rheumatoid arthritis cohort and the benefits of a vaccine booster dose

    Cohort study

  32. Clin Exp Rheumatol

    Can biomarkers predict successful tapering of conventional disease-modifying therapy in rheumatoid arthritis patients in stable remission?

    Cohort study

  33. Scand J Rheumatol

    Cost-effectiveness of a telehealth intervention in rheumatoid arthritis: economic evaluation of the Telehealth in RA (TeRA) randomized controlled trial

    Randomized controlled trial

  34. Scand J Rheumatol

    Increased synovial galectin-3 induce inflammatory fibroblast activation and osteoclastogenesis in patients with rheumatoid arthritis

    Mechanistic study

  35. Scand J Rheumatol

    Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis

    Diagnostic or prognostic study

  36. Clin Exp Rheumatol

    Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study

    Cohort study

  37. Clin Exp Rheumatol

    Haemoglobin changes and disease activity in Japanese patients with rheumatoid arthritis treated with sarilumab

    Secondary analysis

  38. Clin Exp Rheumatol

    New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort

    Cohort study

  39. Clin Exp Rheumatol

    Disease activity in patients with rheumatoid arthritis increases serum levels of apolipoprotein C-III

    Cross-sectional study

  40. Scand J Rheumatol

    Elevated Fab glycosylation of anti-hinge antibodies

    Cross-sectional study

All 1,564 Briefs in ExploreShowing Briefs 1,521–1,560 of 1,564, newest first